These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

197 related items for PubMed ID: 9546366

  • 1. Analysis and clinical implications of p53 gene mutations and human papillomavirus type 16 and 18 infection in primary adenocarcinoma of the uterine cervix.
    Tenti P, Pavanello S, Padovan L, Spinillo A, Vesentini N, Zappatore R, Migliora P, Zara C, Ranzani GN, Carnevali L.
    Am J Pathol; 1998 Apr; 152(4):1057-63. PubMed ID: 9546366
    [Abstract] [Full Text] [Related]

  • 2. Alterations of the p53 gene in human primary cervical carcinoma with and without human papillomavirus infection.
    Fujita M, Inoue M, Tanizawa O, Iwamoto S, Enomoto T.
    Cancer Res; 1992 Oct 01; 52(19):5323-8. PubMed ID: 1327506
    [Abstract] [Full Text] [Related]

  • 3. Correlation between human papillomavirus positivity and p53 gene overexpression in adenocarcinoma of the uterine cervix.
    Uchiyama M, Iwasaka T, Matsuo N, Hachisuga T, Mori M, Sugimori H.
    Gynecol Oncol; 1997 Apr 01; 65(1):23-9. PubMed ID: 9103386
    [Abstract] [Full Text] [Related]

  • 4. Adenocarcinoma of the uterine cervix in Ireland and Sweden: human papillomavirus infection and biologic alterations.
    Skyldberg BM, Murray E, Lambkin H, Kelehan P, Auer GU.
    Mod Pathol; 1999 Jul 01; 12(7):675-82. PubMed ID: 10430271
    [Abstract] [Full Text] [Related]

  • 5. Analysis of human papillomavirus infection and molecular alterations in adenocarcinoma of the cervix.
    Ferguson AW, Svoboda-Newman SM, Frank TS.
    Mod Pathol; 1998 Jan 01; 11(1):11-8. PubMed ID: 9556417
    [Abstract] [Full Text] [Related]

  • 6. The status of human papillomavirus and tumor suppressor genes p53 and p16 in carcinomas of uterine cervix from India.
    Munirajan AK, Kannan K, Bhuvarahamurthy V, Ishida I, Fujinaga K, Tsuchida N, Shanmugam G.
    Gynecol Oncol; 1998 Jun 01; 69(3):205-9. PubMed ID: 9648588
    [Abstract] [Full Text] [Related]

  • 7. [Ha-ras and p53 gene mutations scanned by PCR-SSCP in premalignant and malignant lesions of the uterine cervix associated with human papillomavirus].
    Alonio LV, Dalbert D, Picconi MA, Cervantes Vazquez G, García Carrancá A, Distefano AL, Mural J, Bartt O, Bazan G, Teyssie AR.
    Medicina (B Aires); 2000 Jun 01; 60(6):895-901. PubMed ID: 11436698
    [Abstract] [Full Text] [Related]

  • 8. "Low-risk" and "high-risk" HPV-infection and K-ras gene point mutations in human cervical cancer: a study of 31 cases.
    Stenzel A, Semczuk A, Rózyńskal K, Jakowicki J, Wojcierowski J.
    Pathol Res Pract; 2001 Jun 01; 197(9):597-603. PubMed ID: 11569923
    [Abstract] [Full Text] [Related]

  • 9. The presence of high-risk HPV combined with specific p53 and p16INK4a expression patterns points to high-risk HPV as the main causative agent for adenocarcinoma in situ and adenocarcinoma of the cervix.
    Zielinski GD, Snijders PJ, Rozendaal L, Daalmeijer NF, Risse EK, Voorhorst FJ, Jiwa NM, van der Linden HC, de Schipper FA, Runsink AP, Meijer CJ.
    J Pathol; 2003 Dec 01; 201(4):535-43. PubMed ID: 14648656
    [Abstract] [Full Text] [Related]

  • 10. Integration status of virus DNA and p53 codon 72 polymorphism in human papillomavirus type 16 positive cervical cancers.
    Szarka K, Veress G, Juhász A, Kónya J, Sápy T, Soós G, Hernádi Z, Gergely L.
    Anticancer Res; 2000 Dec 01; 20(3B):2161-7. PubMed ID: 10928171
    [Abstract] [Full Text] [Related]

  • 11. Elderly Japanese women with cervical carcinoma show higher proportions of both intermediate-risk human papillomavirus types and p53 mutations.
    Nakagawa S, Yoshikawa H, Jimbo H, Onda T, Yasugi T, Matsumoto K, Kino N, Kawana K, Kozuka T, Nakagawa K, Aoki M, Taketani Y.
    Br J Cancer; 1999 Mar 01; 79(7-8):1139-44. PubMed ID: 10098748
    [Abstract] [Full Text] [Related]

  • 12. Human papillomavirus detection and p53 expression in clear-cell adenocarcinoma of the vagina and cervix.
    Waggoner SE, Anderson SM, Van Eyck S, Fuller J, Luce MC, Herbst AL.
    Obstet Gynecol; 1994 Sep 01; 84(3):404-8. PubMed ID: 8058239
    [Abstract] [Full Text] [Related]

  • 13. [Human papillomavirus, human cytomegalovirus and p53 gene in cervical carcinoma].
    Zhao W, Si J, Li K.
    Zhonghua Fu Chan Ke Za Zhi; 1995 Nov 01; 30(11):654-7. PubMed ID: 8745488
    [Abstract] [Full Text] [Related]

  • 14. Mutations in the p53 gene and human papillomavirus infection as significant prognostic factors in squamous cell carcinomas of the oral cavity.
    Chiba I, Shindoh M, Yasuda M, Yamazaki Y, Amemiya A, Sato Y, Fujinaga K, Notani K, Fukuda H.
    Oncogene; 1996 Apr 18; 12(8):1663-8. PubMed ID: 8622886
    [Abstract] [Full Text] [Related]

  • 15. Human papillomavirus DNA in invasive cervical carcinomas and its association with patient survival: a nested case-control study.
    Franco E, Bergeron J, Villa L, Arella M, Richardson L, Arseneau J, Stanimir G.
    Cancer Epidemiol Biomarkers Prev; 1996 Apr 18; 5(4):271-5. PubMed ID: 8722218
    [Abstract] [Full Text] [Related]

  • 16. Relationships between c-Ki-ras mutations, HPV types, and prognostic indicators in invasive endocervical adenocarcinomas.
    Koulos JP, Wright TC, Mitchell MF, Silva E, Atkinson EN, Richart RM.
    Gynecol Oncol; 1993 Mar 18; 48(3):364-9. PubMed ID: 8385060
    [Abstract] [Full Text] [Related]

  • 17. Correspondence re: Ferguson AM, Svoboda-Newman SM, Frank TS: Analysis of human papillomavirus infection and molecular alterations in adenocarcinoma of the cervix. Mod Pathol 1:11-18, 1998.
    Tenti P, Zappatore R, Carnevali L.
    Mod Pathol; 1999 Dec 18; 12(12):1192-3. PubMed ID: 10619275
    [No Abstract] [Full Text] [Related]

  • 18. Loss of heterozygosity of the retinoblastoma and p53 genes in primary cervical carcinomas with human papillomavirus infection.
    Kim JW, Lee CG, Han SM, Kim KS, Kim JO, Lee JM, Kim IK, Namkoong SE.
    Gynecol Oncol; 1997 Nov 18; 67(2):215-21. PubMed ID: 9367711
    [Abstract] [Full Text] [Related]

  • 19. Factors predicting the persistence of genital human papillomavirus infections and PAP smear abnormality in HIV-positive and HIV-negative women during prospective follow-up.
    Branca M, Garbuglia AR, Benedetto A, Cappiello T, Leoncini L, Migliore G, Agarossi A, Syrjänen K, DIANAIDS Collaborative Study Group.
    Int J STD AIDS; 2003 Jun 18; 14(6):417-25. PubMed ID: 12816671
    [Abstract] [Full Text] [Related]

  • 20. Correlation between HPV positivity and state of the p53 gene in cervical carcinoma cell lines.
    Iwasaka T, Oh-uchida M, Matsuo N, Yokoyama M, Fukuda K, Hara K, Fukuyama K, Hori K, Sugimori H.
    Gynecol Oncol; 1993 Jan 18; 48(1):104-9. PubMed ID: 8380785
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.